These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19199275)

  • 1. Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score.
    Sugihara M
    Pharm Stat; 2010; 9(1):21-34. PubMed ID: 19199275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of treatment effect adjusting for treatment changes using the intensity score method: application to a large primary prevention study for coronary events (MEGA study).
    Tanaka Y; Matsuyama Y; Ohashi Y;
    Stat Med; 2008 May; 27(10):1718-33. PubMed ID: 17922525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
    Yoshida M; Matsuyama Y; Ohashi Y;
    Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods.
    Matsuyama Y; Yamaguchi T
    Pharm Stat; 2008; 7(3):202-14. PubMed ID: 17554753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized propensity score for estimating the average treatment effect of multiple treatments.
    Feng P; Zhou XH; Zou QM; Fan MY; Li XS
    Stat Med; 2012 Mar; 31(7):681-97. PubMed ID: 21351291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
    Simes J; Furberg CD; Braunwald E; Davis BR; Ford I; Tonkin A; Shepherd J
    Eur Heart J; 2002 Feb; 23(3):207-15. PubMed ID: 11792135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marginal mean weighting through stratification: a generalized method for evaluating multivalued and multiple treatments with nonexperimental data.
    Hong G
    Psychol Methods; 2012 Mar; 17(1):44-60. PubMed ID: 21843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Introduction to an individual-based standardization method -- propensity score weighting].
    Li ZW; Liu JM; Ren AG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb; 31(2):223-6. PubMed ID: 21215089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
    McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
    Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the objectives of and the approaches to propensity score analyses.
    Heinze G; Jüni P
    Eur Heart J; 2011 Jul; 32(14):1704-8. PubMed ID: 21362706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical power in parallel group point exposure studies with time-to-event outcomes: an empirical comparison of the performance of randomized controlled trials and the inverse probability of treatment weighting (IPTW) approach.
    Austin PC; Schuster T; Platt RW
    BMC Med Res Methodol; 2015 Oct; 15():87. PubMed ID: 26472109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighted Kaplan-Meier estimators for two-stage treatment regimes.
    Miyahara S; Wahed AS
    Stat Med; 2010 Nov; 29(25):2581-91. PubMed ID: 20799259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced statistics: the propensity score--a method for estimating treatment effect in observational research.
    Newgard CD; Hedges JR; Arthur M; Mullins RJ
    Acad Emerg Med; 2004 Sep; 11(9):953-61. PubMed ID: 15347546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.
    Sabatine MS; Ploughman L; Simonsen KL; Iakoubova OA; Kirchgessner TG; Ranade K; Tsuchihashi Z; Zerba KE; Long DU; Tong CH; Packard CJ; Pfeffer MA; Devlin JJ; Shepherd J; Campos H; Sacks FM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):562-7. PubMed ID: 18174457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Propensity score methods for creating covariate balance in observational studies].
    Pattanayak CW; Rubin DB; Zell ER
    Rev Esp Cardiol; 2011 Oct; 64(10):897-903. PubMed ID: 21872981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of relative risk and prevalence ratio.
    Savu A; Liu Q; Yasui Y
    Stat Med; 2010 Sep; 29(22):2269-81. PubMed ID: 20564738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.